Chronic treatment with MK-801 decreases D2 dopamine receptor function in rat striatum
Authors:
- 31 March 1993
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 44 (3) , 683-687
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of miceEuropean Journal of Pharmacology, 1991
- Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized ratsNeuropharmacology, 1990
- Synergistic blockade of some dopamine-mediated behaviours by (?)-sulpiride and SCH 23390 in the ratPsychopharmacology, 1989
- Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in miceThe FASEB Journal, 1989
- Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis StudyJournal of Neurochemistry, 1988
- MK-801 is neuroprotective in gerbils when administered during the post-ischaemic periodNeuroscience, 1988
- Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonistsPharmacology Biochemistry and Behavior, 1988
- Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbilJournal of Neuroscience, 1987
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975